It's been more than 40 years since rocks from the moon have come back to Earth. But in late November, a Chinese craft landed on the moon's surface--it's the country's first mission designed to retrieve samples of the moon's surface. The mission is called Chang'e-5, in honor of the moon goddess. NPR science correspondent Geoff Brumfiel tells us what the mission will tell us about the solar system, and how it foreshadows China's future ambitions on Earth and in space. Email us at shortwave@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Wissenschaft & Technik
Short Wave Folgen
New discoveries, everyday mysteries, and the science behind the headlines — in just under 15 minutes. It's science for everyone, using a lot of creativity and a little humor. Join hosts Emily Kwong and Regina Barber for science on a different wavelength.If you're hooked, try Short Wave Plus. Your subscription supports the show and unlocks a sponsor-free feed. Learn more at plus.npr.org/shortwave
Folgen von Short Wave
1329 Folgen
-
Folge vom 11.12.2020Chang'e-5: To The Moon And Back
-
Folge vom 10.12.2020Climate Change And 2020's Record-Breaking Hurricane SeasonThe 2020 Atlantic Hurricane season broke records and caused enormous damage. NPR climate reporter Rebecca Hersher talks us through the 2020 season--what was driven by climate change and what it means for the future. Email the show at shortwave@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 08.12.2020Science From Curiosity And A Little PaperManu Prakash is the co-inventor of the Foldscope, a low-cost microscope aimed at making scientific tools more accessible. We chat with him about why he wants to change how we think about science, and what it'll take to make science something everyone is able to enjoy. (Encore episode) Follow Maddie on Twitter. Email the show at shortwave@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy
-
Folge vom 07.12.2020How Effective Are Antibody Treatments For COVID-19?The FDA has issued emergency use authorizations for two monoclonal antibody treatments for COVID-19 – one produced by Eli Lilly and another by Regeneron. As science correspondent Richard Harris explains, emergency use authorization doesn't assure that these new drugs are effective, but that their potential benefits are likely to outweigh the risks. So today, we get to the bottom of how this type of treatment works and if they'll really make a difference.Email the show your questions, coronavirus or otherwise, at shortwave@npr.org.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy